- Issuer ticker
-
ANIK
- Reported as of
-
03 Aug 2026
- Net transaction value
-
+$41,060
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
05 Aug 2026, 16:30:12 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Gary P. Fischetti
Key filing fact
Gary P. Fischetti filed Form 4 for Anika Therapeutics, Inc. (ANIK) on 05 Aug 2026.
Key facts
- This page summarizes Gary P. Fischetti's Form 4 filing for Anika Therapeutics, Inc. (ANIK).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2026, 16:30.
Change
- Previous filing in this sequence was filed on 23 Jun 2026.
- Current net transaction value: +$41,060.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001929510
Primary reporting owner
Fischetti Gary P
- Relationship
-
Director
- Address
- C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD
- Signature
- /s/ Gary P. Fischetti
- Signature date
- 05 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANIK
transaction
Common Stock
Purchase
- Transaction value
- $20,745
- Shares
- +1,000
- Change %
- +1.9%
- Price
-
$20.74
- Shares after
- 53,015
- Date
- 03 Aug 2026
- Ownership
- Direct
ANIK
transaction
Common Stock
Purchase
- Transaction value
- $20,315
- Shares
- +1,000
- Change %
- +1.9%
- Price
-
$20.32
- Shares after
- 54,015
- Date
- 04 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.